Zacks Research Reduces Earnings Estimates for Helen of Troy

Helen of Troy Limited (NASDAQ:HELE) – Investment analysts at Zacks Research dropped their FY2026 earnings per share (EPS) estimates for shares of Helen of Troy in a research note issued to investors on Thursday, January 22nd. Zacks Research analyst Team now expects that the company will post earnings per share of $2.60 for the year, down from their prior estimate of $3.25. Zacks Research currently has a “Strong Sell” rating on the stock. The consensus estimate for Helen of Troy’s current full-year earnings is $6.46 per share. Zacks Research also issued estimates for Helen of Troy’s Q4 2026 earnings at $0.53 EPS, Q1 2027 earnings at ($0.09) EPS, Q2 2027 earnings at $0.09 EPS, Q3 2027 earnings at $1.78 EPS, Q4 2027 earnings at $0.97 EPS, FY2027 earnings at $2.76 EPS, Q1 2028 earnings at $0.15 EPS, Q2 2028 earnings at $0.28 EPS, Q3 2028 earnings at $1.92 EPS and FY2028 earnings at $3.45 EPS.

Helen of Troy (NASDAQ:HELE) last posted its earnings results on Thursday, January 8th. The company reported $1.71 earnings per share for the quarter, missing the consensus estimate of $1.75 by ($0.04). Helen of Troy had a negative net margin of 43.97% and a positive return on equity of 8.33%. The company had revenue of $512.83 million during the quarter, compared to analyst estimates of $502.42 million. During the same quarter last year, the business posted $2.67 EPS. The firm’s revenue for the quarter was down 3.4% on a year-over-year basis. Helen of Troy has set its FY 2026 guidance at 3.250-3.75 EPS and its Q4 2026 guidance at 0.530-1.030 EPS.

Other analysts have also recently issued reports about the company. Canaccord Genuity Group set a $22.00 price objective on Helen of Troy in a research note on Friday, January 9th. UBS Group reduced their price target on Helen of Troy from $25.00 to $22.00 and set a “neutral” rating on the stock in a research report on Friday, January 9th. Weiss Ratings reissued a “sell (d-)” rating on shares of Helen of Troy in a research report on Monday, December 29th. Finally, CJS Securities raised shares of Helen of Troy to a “strong-buy” rating in a report on Thursday, December 11th. One research analyst has rated the stock with a Strong Buy rating, two have issued a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $22.00.

Helen of Troy Stock Performance

Shares of HELE stock opened at $18.30 on Monday. The firm has a 50 day moving average of $19.83 and a two-hundred day moving average of $21.58. The stock has a market capitalization of $422.18 million, a PE ratio of -0.53 and a beta of 0.78. The company has a quick ratio of 0.90, a current ratio of 1.81 and a debt-to-equity ratio of 1.02. Helen of Troy has a 52 week low of $17.01 and a 52 week high of $69.05.

Institutional Investors Weigh In On Helen of Troy

Hedge funds and other institutional investors have recently bought and sold shares of the stock. iSAM Funds UK Ltd purchased a new position in shares of Helen of Troy during the third quarter worth about $27,000. Farther Finance Advisors LLC grew its stake in Helen of Troy by 5,529.2% during the 4th quarter. Farther Finance Advisors LLC now owns 1,351 shares of the company’s stock worth $29,000 after buying an additional 1,327 shares during the last quarter. Larson Financial Group LLC increased its position in Helen of Troy by 1,323.2% during the third quarter. Larson Financial Group LLC now owns 1,352 shares of the company’s stock worth $34,000 after buying an additional 1,257 shares during the period. Signaturefd LLC increased its position in Helen of Troy by 71.1% during the second quarter. Signaturefd LLC now owns 1,429 shares of the company’s stock worth $41,000 after buying an additional 594 shares during the period. Finally, Tower Research Capital LLC TRC lifted its stake in Helen of Troy by 216.1% in the second quarter. Tower Research Capital LLC TRC now owns 1,998 shares of the company’s stock valued at $57,000 after buying an additional 1,366 shares during the last quarter.

Helen of Troy News Summary

Here are the key news stories impacting Helen of Troy this week:

• Positive Sentiment: Zacks raised its Q3 2028 EPS estimate to $1.92 (from $1.71), signaling a stronger seasonal quarter ahead for Helen of Troy. Zacks Q3 2028 raise
• Positive Sentiment: Zacks also raised its Q2 2028 EPS forecast to $0.28 (from $0.17), another near‑term upside revision. Zacks Q2 2028 raise
• Positive Sentiment: Q3 2027 EPS was nudged higher to $1.78 (from $1.70), a modest improvement for that quarter. Zacks Q3 2027 raise
• Neutral Sentiment: Zacks trimmed FY2028 slightly to $3.45 from $3.57 — a modest downward revision that suggests smaller long‑term impact versus the larger near‑term cuts. Zacks FY2028 trim
• Negative Sentiment: Zacks slashed Q4 2026 EPS to $0.53 from $1.14, a material downward revision that reduces near‑term earnings visibility. Zacks Q4 2026 cut
• Negative Sentiment: FY2026 EPS was cut sharply to $2.60 from $3.25 and FY2027 to $2.76 from $3.36, indicating Zacks expects lower full‑year profitability over the next two years. Zacks FY2026/2027 cuts
• Negative Sentiment: Zacks now models Q1 2027 as a loss (‑$0.09 EPS) and reduced several other near‑quarter forecasts; the firm maintains a “Strong Sell” rating, which is a clear negative for market sentiment. Zacks Strong Sell

About Helen of Troy

Helen of Troy Limited is a global consumer products company that designs, sources and markets a diversified portfolio of household, health and beauty brands. Headquartered in El Paso, Texas, the company operates through three principal segments—Health & Home, Housewares and Beauty—offering products under well-known names including OXO, Vicks, Braun, Honeywell Home, PUR and Hot Tools. Helen of Troy distributes its products through a combination of mass, specialty and e-commerce channels to consumers, retailers and distributors worldwide.

The Housewares segment features kitchen tools, gadgets and organizational solutions marketed primarily under the OXO brand, recognized for its ergonomic “Good Grips” design.